Mesalamine Tablet, Delayed Release
Product Images NDC 0591-2245

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 0591-2245). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 1)

This is a chemical formula for a molecule containing carbon (C), hydrogen (H), nitrogen (N), and oxygen (O). The exact compound name or purpose cannot be determined from this information.*

FDA Label Image

1 (Image 2)

This is prescribing information for Mesalamine Delayed-Release Tablets, USP which come in a bottle containing 120 tablets. The tablets are designed for once-daily use and each contains 5mg of the active ingredient. The medication is dispensed by a pharmacist and must be kept at a controlled room temperature. This product is manufactured by Actavis, a pharmaceutical company based in the United States.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.